Quest Laboratories Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board has announced a meeting outcome detailing the approval and recording of unaudited financial results for the half-year ended September 30, 2024. Total income stood at ₹43.46 Cr, while net profit after tax was ₹8.01 Cr, reflecting robust performance. Total shareholders' funds were reported at ₹79.81 Cr. The company remains focused on its core business in drug manufacturing, as indicated by solid financials, highlighting a positive trajectory for stakeholders. Financial transparency has been emphasized with a review by statutory auditors.